Chris Grenga

increasingly constructive commentary across broader life sciences recently, just in terms of what you're seeing

You had highlighted the UAV opportunity, and I was just curious if you could provide a little bit more color

Can you walk us through the specific bridge items that are driving the revision? And how much of that is operational versus capital structure below the line?

Could you talk about what you are seeing in customer engagement since the launch of that product?

could those translate into tailwinds for Zebra as customers adopt more of Zebra's technologies to enhance their tariff compliance

The deployment of Zebra companion with AI features at the anchor customer that showcased the NRF progressing in line with your expectations

Do you anticipate the feature set for Companion being exclusive to the customer that was showcased in our effort for any period of time